13D/13G Filings - Cormorant Asset Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
3:08 pm
Purchase
2021-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,440,451
9.770%
325,607increase
(+6.37%)
Filing
History
2022-02-14
3:07 pm
Sale
2021-12-31 13G BioAtla, Inc.
BCAB
Cormorant Asset Management LP 2,038,215
5.770%
-253,845decrease
(-11.07%)
Filing
History
2022-02-14
3:06 pm
Sale
2021-12-31 13G Avidity Biosciences, Inc.
RNA
Cormorant Asset Management LP 2,012,115
4.290%
-452,432decrease
(-18.36%)
Filing
History
2022-02-14
3:05 pm
Sale
2021-12-31 13G Atea Pharmaceuticals, Inc.
AVIR
Cormorant Asset Management LP 1,679,442
2.020%
-4,731,913decrease
(-73.81%)
Filing
History
2022-02-14
3:04 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
Cormorant Asset Management LP 1,436,322
6.280%
1,436,322increase
(New Position)
Filing
History
2022-02-14
3:04 pm
Sale
2021-12-31 13G Otonomy, Inc.
OTIC
Cormorant Asset Management LP 0
0.000%
-2,600,000decrease
(Position Closed)
Filing
2022-02-14
3:03 pm
Sale
2021-12-31 13G Omeros Corporation
OMER
Cormorant Asset Management LP 0
0.000%
-5,000,000decrease
(Position Closed)
Filing
History
2022-02-14
3:02 pm
Purchase
2021-12-31 13G Turning Point Therapeutics, Inc.
TPTX
Cormorant Asset Management LP 3,025,000
6.110%
632,703increase
(+26.45%)
Filing
History
2022-02-14
3:01 pm
Sale
2021-12-31 13G Olema Pharmaceuticals, Inc.
OLMA
Cormorant Asset Management LP 2,169,871
5.390%
-1,025,673decrease
(-32.10%)
Filing
History
2022-02-14
3:01 pm
Sale
2021-12-31 13G Tarsus Pharmaceuticals, Inc.
TARS
Cormorant Asset Management LP 1,403,331
6.790%
-310,938decrease
(-18.14%)
Filing
History
2022-02-14
3:00 pm
Purchase
2021-12-31 13G Eledon Pharmaceuticals, Inc.
ELDN
Cormorant Asset Management LP 1,428,598
9.900%
1,428,598increase
(New Position)
Filing
History
2021-08-13
4:01 pm
Purchase
2021-08-03 13G Immuneering Corporation
IMRX
Cormorant Asset Management LP 2,252,628
8.830%
2,252,628increase
(New Position)
Filing
History
2021-08-10
4:01 pm
Unchanged
2021-07-26 13D Erasca, Inc.
ERAS
Cormorant Asset Management LP 10,505,553
8.830%
0
(Unchanged)
Filing
History
2021-07-30
4:01 pm
Purchase
2021-07-20 13D Erasca, Inc.
ERAS
Cormorant Asset Management LP 10,505,553
8.830%
10,505,553increase
(New Position)
Filing
History
2021-07-12
4:19 pm
Purchase
2021-07-02 13G Aerovate Therapeutics, Inc.
AVTE
Cormorant Asset Management LP 58,020
8.320%
58,020increase
(New Position)
Filing
History
2021-07-09
4:06 pm
Purchase
2021-06-29 13G Elevation Oncology, Inc.
ELEV
Cormorant Asset Management LP 1,983,168
8.690%
1,983,168increase
(New Position)
Filing
History
2021-07-08
4:02 pm
Purchase
2021-06-28 13G Monte Rosa Therapeutics, Inc.
GLUE
Cormorant Asset Management LP 3,193,974
7.180%
3,193,974increase
(New Position)
Filing
History
2021-07-02
4:12 pm
Purchase
2021-06-22 13G Ambrx Biopharma Inc.
AMAM
Cormorant Asset Management LP 17,404,702
6.600%
17,404,702increase
(New Position)
Filing
History
2021-05-19
4:09 pm
Purchase
2021-05-18 13G Revolution Medicines, Inc.
RVMD
Cormorant Asset Management LP 3,675,000
5.000%
1,179,934increase
(+47.29%)
Filing
History
2021-04-09
4:07 pm
Purchase
2021-03-30 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,114,844
9.200%
5,114,844increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next